Seragon Pharmaceuticals develops small-molecule drugs for the treatment of estrogen receptor dependent breast cancer. read more
Seragon Pharmaceuticals VP of Investor Relations Salary
$77k
$120k
$129k
$225k
N/A
Average Compensation
VP of Investor Relations Salaries at Seragon Pharmaceuticals
Compensation at Seragon Pharmaceuticals by Department
The Communications Department averages $9,929 more than the Enterprise Risk Department.
Communications
$195,641 Enterprise Risk
$185,712 -$10k
Product
$151,052 -$45k
How VPs of Investor Relations at Seragon Pharmaceuticals Rate Their Compensation
The majority of VPs of Investor Relations at Seragon Pharmaceuticals believe they're compensated fairly. 50% of VPs of Investor Relations at Seragon Pharmaceuticals say they receive annual bonuses, and the majority (67%) are satisfied with their benefits. See more compensation ratings at Seragon Pharmaceuticals
VP of Investor Relations Salaries at Similar Size Companies
×